Spire Wealth Management Meridian Bioscience Inc Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$19.97 - $26.94 $45,611 - $61,530	-2,284 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$17.46 - $21.61 $39,878 - $49,357	2,284 New	2,284 $47,000
Q2 2021 Jul 26, 2021	SELL	$18.01 - $28.32 $41,134 - $64,682	-2,284 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$19.76 - $29.89 $45,131 - $68,268	2,284 New	2,284 $84,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.